AAAAAA
Results:
1-7
|
Results: 7
Authors:
Calero, M
Pawlik, M
Soto, C
Castano, EM
Sigurdsson, EM
Kumar, A
Gallo, G
Frangione, B
Levy, E
Citation: M. Calero et al., Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type, J NEUROCHEM, 77(2), 2001, pp. 628-637
Authors:
Sigurdsson, EM
Scholtzova, H
Mehta, PD
Frangione, B
Wisniewski, T
Citation: Em. Sigurdsson et al., Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice, AM J PATH, 159(2), 2001, pp. 439-447
Authors:
Wisniewski, T
Sigurdsson, EM
Aucouturier, P
Frangione, B
Citation: T. Wisniewski et al., Conformation as therapeutic target in the prionoses and other neurodegenerative conditions, METH MOL M, 59, 2001, pp. 223-236
Authors:
Sigurdsson, EM
Permanne, B
Soto, C
Wisniewski, T
Frangione, B
Citation: Em. Sigurdsson et al., In vivo reversal of amyloid-beta lesions in rat brain, J NE EXP NE, 59(1), 2000, pp. 11-17
Authors:
Chambers, CB
Sigurdsson, EM
Hejna, MJ
Lorens, SA
Lee, JM
Muma, NA
Citation: Cb. Chambers et al., Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression, EXP NEUROL, 162(1), 2000, pp. 158-170
Authors:
Soto, C
Sigurdsson, EM
Morelli, L
Kumar, RA
Saborio, GP
Castano, EM
Frangione, B
Citation: C. Soto et al., beta-sheet breaker peptides prevent the formation of fibrillar amyloid-beta deposits, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 729-732
Authors:
Sigurdsson, EM
Morelli, L
Kumar, RA
Castano, EM
Frangione, B
Soto, C
Citation: Em. Sigurdsson et al., beta-sheet breaker peptides as potential therapy for Alzheimer's disease, ALZHEIM REP, 1, 1998, pp. S35-S36
Risultati:
1-7
|